Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis
- PMID: 1551335
- DOI: 10.1007/BF01307568
Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis
Abstract
We examined the distribution of colonic mucosal mast cells in 25 patients with active ulcerative colitis, with a clear line of demarcation separating active inflammation from normal mucosa. Biopsies, at least one adjacent to the line of demarcation, one in inflamed mucosa, and one above were obtained during colonoscopy. Eight patients had elevated mast cells throughout the colon, and 12 had increased numbers at the line of demarcation of disease. Mean numbers of mast cells from these patients were 6.3 (+/- 2.1 SD) in active inflammation, 19.5 (+/- 7.1 SD) at the line of demarcation, and 15.8 (+/- 8.4 SD) in normal mucosa. Histologic inflammation decreased as mast cells increased. The accumulation of mast cells at the visible line of demarcation between normal and abnormal mucosa suggests mast cells play a critical role in either accelerating the process of inflammation or in suppressing continued extension of the disease.
Similar articles
-
Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.Hepatogastroenterology. 1997 Mar-Apr;44(14):435-40. Hepatogastroenterology. 1997. PMID: 9164515
-
Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.Hepatogastroenterology. 1999 Mar-Apr;46(26):920-3. Hepatogastroenterology. 1999. PMID: 10370639
-
Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?Gut. 1988 Apr;29(4):516-21. doi: 10.1136/gut.29.4.516. Gut. 1988. PMID: 3371720 Free PMC article.
-
[Diagnosis of ulcerative colitis and the biopsy method].Nihon Rinsho. 1999 Nov;57(11):2457-60. Nihon Rinsho. 1999. PMID: 10572411 Review. Japanese.
-
Advanced endoscopic imaging for dysplasia surveillance in ulcerative colitis.Expert Rev Gastroenterol Hepatol. 2013 Jan;7(1):57-67. doi: 10.1586/egh.12.65. Expert Rev Gastroenterol Hepatol. 2013. PMID: 23265150 Review.
Cited by
-
Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy.Sci Rep. 2021 Apr 27;11(1):9010. doi: 10.1038/s41598-021-88489-w. Sci Rep. 2021. PMID: 33907256 Free PMC article.
-
Key role of mast cells and their major secretory products in inflammatory bowel disease.World J Gastroenterol. 2004 Feb 1;10(3):309-18. doi: 10.3748/wjg.v10.i3.309. World J Gastroenterol. 2004. PMID: 14760748 Free PMC article. Review.
-
Distribution of mast cells in human ileocecal region.Dig Dis Sci. 1995 Feb;40(2):357-65. doi: 10.1007/BF02065422. Dig Dis Sci. 1995. PMID: 7531634
-
The PAD4 inhibitor GSK484 diminishes neutrophil extracellular trap in the colon mucosa but fails to improve inflammatory biomarkers in experimental colitis.Biosci Rep. 2025 May 20;45(6):375-97. doi: 10.1042/BSR20253205. Online ahead of print. Biosci Rep. 2025. PMID: 40459411 Free PMC article.
-
Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation.World J Gastroenterol. 2007 Jun 14;13(22):3027-30. doi: 10.3748/wjg.v13.i22.3027. World J Gastroenterol. 2007. PMID: 17589915 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Medical